• 2007

Company Description

Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.

Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.